StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
187420.KQ$2120.00-1.40%
Fair $2120.00+0.0%

187420.KQ

HLB Genex, Inc.

Basic Materials / Specialty ChemicalsKOSDAQ

$2120.00

-30.00 (-1.40%)

Fairly Valued+0.0%Fair Value $2120.00Fund rank 25/100 · Data gapFallback financials|
SA 40/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $2.2B · quality 38.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · 187420.KQLocal privado en este navegador · HLB Genex, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$61.8B

P/E

3.5x

↓

EV/EBITDA

1.8x

↓

ROE

55.2%

↑

Gross Margin

35.0%

↑

Debt/Equity

1.06

↑
52-Week Range$2120
$2015$3785

TradingView lightweight chart

187420.KQ price, volumen y niveles de valoración

Último $2,120Periodo -83.2%
Fair value: $2,120

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+16.0%

FCF CAGR

—

FCF margin

5.6%

FCF / Net income

0.11x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $43.37B · net income $22.59B · FCF $2.43B

2022-FY → 2025-FY

Gross margin

35.0%-1.7% pts

Operating margin

2.9%+25.3% pts

Net margin

52.1%+98.7% pts

FCF margin

5.6%+38.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$43.37B$43.37B$35.43B$27.01B$27.80B
Net Income$22.59B$22.59B$-18.83B$-2.95B$-12.97B
EBITDA$39.37B$39.37B$-8.15B$9.36B$-565.9M
EPS606.00606.00-800.00-130.00-576.00
Gross Margin35.0%35.0%40.4%27.1%36.7%
Operating Margin2.9%2.9%-5.3%-35.0%-22.4%
Net Margin52.1%52.1%-53.1%-10.9%-46.6%
Balance Sheet
Debt/Equity1.061.061.882.833.29
Current Ratio0.820.82———
Cash Flow
Free Cash Flow$2.43B$2.43B$2.17B$-6.15B$-9.03B
Returns
ROE55.2%55.2%-79.2%-13.4%-54.3%
Valuation
P/E3.503.50———
EV/EBITDA1.821.82—14.35—
P/B1.511.515.004.305.82
Growth & Yield
Revenue Growth22.4%22.4%31.2%-2.9%—
EPS Growth175.8%175.8%-515.4%77.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-32.3%

fácil

EPS terminal req.

$188.11

Spread vs growth

208.0%

5Y implied EPS CAGR

-17.8%

fácil

EPS terminal req.

$227.62

Spread vs growth

193.5%

10Y implied EPS CAGR

-4.9%

fácil

EPS terminal req.

$366.58

Spread vs growth

180.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -38.2%

Total return

-38.2%

Start / end P/E

n/dx → n/dx

EPS bridge

-800.00 → 606.00

Residual

-38.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-38.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.